On Friday, Macrogenics Inc (NASDAQ: MGNX) was 4.12% up from the session before settling in for the closing price of $1.7. A 52-week range for MGNX has been $0.99 – $5.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 19.47%. When this article was written, the company’s average yearly earnings per share was at -63.44%. With a float of $58.06 million, this company’s outstanding shares have now reached $63.21 million.
Macrogenics Inc (MGNX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Macrogenics Inc stocks. The insider ownership of Macrogenics Inc is 8.14%, while institutional ownership is 71.35%. The most recent insider transaction that took place on Aug 19 ’25, was worth 76,760. In this transaction Director of this company bought 50,500 shares at a rate of $1.52, taking the stock ownership to the 61,500 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 49,500 for $1.49, making the entire transaction worth $73,755. This insider now owns 111,000 shares in total.
Macrogenics Inc (MGNX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted 0.9 earnings per share (EPS) during the time that was better than consensus figure (set at 0.6) by 0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
You can see what Macrogenics Inc (MGNX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.63 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Compared to the last year’s volume of 0.91 million, its volume of 0.87 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 67.44%.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 65.22%, which indicates a significant decrease from 77.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1234 in the past 14 days, which was lower than the 0.1338 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5334, while its 200-day Moving Average is $2.1730. Nevertheless, the first resistance level for the watch stands at $1.8064 in the near term. At $1.8429, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8907. If the price goes on to break the first support level at $1.7221, it is likely to go to the next support level at $1.6743. Should the price break the second support level, the third support level stands at $1.6378.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
There are 63,206K outstanding shares of the company, which has a market capitalization of 111.87 million. As of now, sales total 149,960 K while income totals -66,970 K. Its latest quarter income was 22,240 K while its last quarter net income were -36,250 K.
